Related references
Note: Only part of the references are listed.The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas
R.C. BELJAARDS et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Primary cutaneous Hodgkin lymphoma
Guglielmo Pranteda et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders
M. F. Benner et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Primary cutaneous Hodgkin's lymphoma
M. Mukesh et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2009)
Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis
Graham W. Slack et al.
LEUKEMIA & LYMPHOMA (2009)
Diagnostic Utility of the B-cell Lineage Markers CD20, CD79a, PAX5. and CD19 in Paraffin-embedded Tissues From Lymphoid Neoplasms
Heiner Adams et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2009)
PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells
Grazia Fazio et al.
CANCER RESEARCH (2008)
The Frequency of Immunoglobulin Heavy Chain Gene and T-Cell Receptor γ-Chain Gene Rearrangements and Epstein-Barr Virus in ALK+ and ALK- Anaplastic Large Cell Lymphoma and Other Peripheral T-Cell Lymphomas
Brent T. Tan et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Prognostic impact of CD15 expression and proliferative index in the outcome of children with classical Hodgkin lymphoma
Mdrio Henrique M. Barros et al.
PEDIATRIC BLOOD & CANCER (2008)
Proliferative index and CD15 expression in pediatric classical Hodgkin lymphoma
Veronique Dinand et al.
PEDIATRIC BLOOD & CANCER (2008)
Diagnostic uses of Pax5 immunohistochemistry
Andrew L. Feldman et al.
ADVANCES IN ANATOMIC PATHOLOGY (2007)
Pax-5 immunoexpression in various types of benign and malignant tumours: a high-throughput tissue microarray analysis
Paulette Mhawech-Fauceglia et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
MMA monoclonal antibody is a superior anti-CD15 reagent for the diagnosis of classical Hodgkin's lymphoma
Wilma Pellegrini et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Hodgkin-like anaplastic large cell lymphoma (previously designated in the REAL classification) has same immunophenotypic features to classical Hodgkin lymphoma
Jun-Ichi Tamaru et al.
LEUKEMIA & LYMPHOMA (2007)
Rare expression of BSAP (PAX-5) in mature T-cell lymphomas
Alexandar S. Tzankov et al.
MODERN PATHOLOGY (2007)
Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobuhn heavy-chain locus
Abdallah Souabni et al.
BLOOD (2007)
Systemic and primary cutaneous anaplastic large cell lymphomas
ME Kadin et al.
SEMINARS IN HEMATOLOGY (2003)
CD30(+) cutaneous lymphoproliferative disorders: The Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma
HL Liu et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
The value of anti-Pax-5 immunostaining in routinely fixed and paraffin-embedded sections - A novel pan pre-B and B-cell marker
E Torlakovic et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Pregnancy-associated cytotoxic lymphoma: A report of 4 cases
M Kato et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2001)
Share Paper
